BNP Paribas Financial Markets’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.6K Sell
7,335
-11,423
-61% -$69K ﹤0.01% 4768
2025
Q4
$98.3K Buy
18,758
+8,066
+75% +$31.9K ﹤0.01% 4387
2025
Q3
$46.3K Sell
10,692
-4,868
-31% -$8.75K ﹤0.01% 4630
2025
Q2
$16.3K Buy
15,560
+6,319
+68% +$7.55K ﹤0.01% 4687
2025
Q1
$11.9K Buy
9,241
+2,186
+31% +$3.45K ﹤0.01% 4674
2024
Q4
$17.6K Buy
+7,055
New +$25.1K ﹤0.01% 4747
2022
Q4
Sell
-105,981
Closed -$1.07M 4692
2022
Q3
$1.07M Buy
+105,981
New +$1.06M ﹤0.01% 2431

Other funds holding ZURA

BNP Paribas Financial Markets's ZURA Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Zura Bio (ZURA) stake by 61% in Q1 2026, selling an estimated $69K and leaving 7,335 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4768.

BNP Paribas Financial Markets first reported a position in ZURA in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.07M in Q3 2022. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • BNP Paribas Financial Markets held 7,335 shares of Zura Bio worth $43.6K as of Q1 2026.
  • BNP Paribas Financial Markets sold 11,423 Zura Bio shares in Q1 2026, an estimated $69K.
  • Zura Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4768 holding.
  • BNP Paribas Financial Markets first reported a position in Zura Bio in Q3 2022 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Zura Bio position peaked at $1.07M in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.